138 related articles for article (PubMed ID: 12675600)
1. Precipitation of lysozyme nanoparticles from dimethyl sulfoxide using carbon dioxide as antisolvent.
Muhrer G; Mazzotti M
Biotechnol Prog; 2003; 19(2):549-56. PubMed ID: 12675600
[TBL] [Abstract][Full Text] [Related]
2. A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.
Dong Y; Ng WK; Hu J; Shen S; Tan RB
Int J Pharm; 2010 Feb; 386(1-2):256-61. PubMed ID: 19922777
[TBL] [Abstract][Full Text] [Related]
3. Experimental study of the GAS process for producing microparticles of beclomethasone-17,21-dipropionate suitable for pulmonary delivery.
Bakhbakhi Y; Charpentier PA; Rohani S
Int J Pharm; 2006 Feb; 309(1-2):71-80. PubMed ID: 16412594
[TBL] [Abstract][Full Text] [Related]
4. Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent.
Young TJ; Johnston KP; Mishima K; Tanaka H
J Pharm Sci; 1999 Jun; 88(6):640-50. PubMed ID: 10350502
[TBL] [Abstract][Full Text] [Related]
5. Supercritical fluid assisted atomization introduced by an enhanced mixer for micronization of lysozyme: Particle morphology, size and protein stability.
Du Z; Guan YX; Yao SJ; Zhu ZQ
Int J Pharm; 2011 Dec; 421(2):258-68. PubMed ID: 22001535
[TBL] [Abstract][Full Text] [Related]
6. Ampicillin Nanoparticles Production via Supercritical CO2 Gas Antisolvent Process.
Esfandiari N; Ghoreishi SM
AAPS PharmSciTech; 2015 Dec; 16(6):1263-9. PubMed ID: 25771736
[TBL] [Abstract][Full Text] [Related]
7. Process parameters and morphology in puerarin, phospholipids and their complex microparticles generation by supercritical antisolvent precipitation.
Li Y; Yang DJ; Chen SL; Chen SB; Chan AS
Int J Pharm; 2008 Jul; 359(1-2):35-45. PubMed ID: 18440736
[TBL] [Abstract][Full Text] [Related]
8. Mineralization of CaCO3 in the presence of egg white lysozyme.
Voinescu AE; Touraud D; Lecker A; Pfitzner A; Kunz W; Ninham BW
Langmuir; 2007 Nov; 23(24):12269-74. PubMed ID: 17949115
[TBL] [Abstract][Full Text] [Related]
9. Supercritical fluid processing of proteins. I: lysozyme precipitation from organic solution.
Moshashaée S; Bisrat M; Forbes RT; Nyqvist H; York P
Eur J Pharm Sci; 2000 Sep; 11(3):239-45. PubMed ID: 11042230
[TBL] [Abstract][Full Text] [Related]
10. Rapid, room-temperature synthesis of antibacterial bionanocomposites of lysozyme with amorphous silica or titania.
Luckarift HR; Dickerson MB; Sandhage KH; Spain JC
Small; 2006 May; 2(5):640-3. PubMed ID: 17193101
[No Abstract] [Full Text] [Related]
11. Development in modeling submicron particle formation in two phases flow of solvent-supercritical antisolvent emulsion.
Dukhin SS; Shen Y; Dave R; Pfeffer R
Adv Colloid Interface Sci; 2007 Oct; 134-135():72-88. PubMed ID: 17568550
[TBL] [Abstract][Full Text] [Related]
12. Development of an in situ forming PLGA drug delivery system I. Characterization of a non-aqueous protein precipitation.
Körber M; Bodmeier R
Eur J Pharm Sci; 2008 Nov; 35(4):283-92. PubMed ID: 18721875
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ
Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211
[TBL] [Abstract][Full Text] [Related]
14. Effect of the spraying conditions and nozzle design on the shape and size distribution of particles obtained with supercritical fluid drying.
Bouchard A; Jovanović N; de Boer AH; Martín A; Jiskoot W; Crommelin DJ; Hofland GW; Witkamp GJ
Eur J Pharm Biopharm; 2008 Sep; 70(1):389-401. PubMed ID: 18534833
[TBL] [Abstract][Full Text] [Related]
15. Controlled antisolvent precipitation of spironolactone nanoparticles by impingement mixing.
Dong Y; Ng WK; Shen S; Kim S; Tan RB
Int J Pharm; 2011 May; 410(1-2):175-9. PubMed ID: 21397674
[TBL] [Abstract][Full Text] [Related]
16. Ultrasonically controlled particle size distribution of explosives: a safe method.
Patil MN; Gore GM; Pandit AB
Ultrason Sonochem; 2008 Mar; 15(3):177-87. PubMed ID: 17532248
[TBL] [Abstract][Full Text] [Related]
17. Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme.
Vertegel AA; Siegel RW; Dordick JS
Langmuir; 2004 Aug; 20(16):6800-7. PubMed ID: 15274588
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation.
Zu Y; Sun W; Zhao X; Wang W; Li Y; Ge Y; Liu Y; Wang K
Eur J Pharm Sci; 2014 Mar; 53():109-17. PubMed ID: 24345795
[TBL] [Abstract][Full Text] [Related]
19. Precipitation of Ibuprofen Sodium using compressed carbon dioxide as antisolvent.
Bakhbakhi Y; Alfadul S; Ajbar A
Eur J Pharm Sci; 2013 Jan; 48(1-2):30-9. PubMed ID: 23127825
[TBL] [Abstract][Full Text] [Related]
20. About the solubility of reduced SWCNT in DMSO.
Guan J; Martinez-Rubi Y; Dénommée S; Ruth D; Kingston CT; Daroszewska M; Barnes M; Simard B
Nanotechnology; 2009 Jun; 20(24):245701. PubMed ID: 19471083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
